Clinical Study of the Safety and Immunogenicity of a Recombinant Viral Vector AAV5 (Adeno-Associated Virus Type 5 )-RBD (Receptor Binding Domain)-S Vaccine for the Prevention of Coronavirus Infection (COVID-19)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to COVID-19
Related studies linked through entity extraction aliases.
A Trial Evaluating the Safety and Immunogenicity of 3 COVID-19 SARS-CoV-2 RNA Vaccines in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Noninvasive Multimodal Biosensing Device for Screening and Monitoring Response to Treatment of Infectious Respiratory Diseases
- Status
- COMPLETED
- Phase
- NA
Study on Safety and Clinical Efficacy of AZVUDINE in Initial Stage COVID-19 Patients (SARS-CoV-2 Infected)
- Status
- COMPLETED
- Phase
- PHASE3
Korea Comirnaty Post-marketing Surveillance
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Multisite Observational Maternal and Infant Study for COVID-19
- Status
- COMPLETED
- Phase
- N/A
Low-cost Sensor System for COVID-19 Patient Monitoring: Validation of BRAEBON Vital Signs Monitor (VTS)
- Status
- COMPLETED
- Phase
- N/A
Adverse Events Report of Inactivated COVID-19 Vaccine
- Status
- COMPLETED
- Phase
- N/A
Effects of Inspiratory Muscle Training After Covid-19 (ReCOV)
- Status
- COMPLETED
- Phase
- NA
COVID-19 Vaccine Boosters in Patients With CKD
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States
- Status
- COMPLETED
- Phase
- N/A
Safety and Immunogenicity of COVID-19 Vaccination in Patients With Cancer
- Status
- UNKNOWN
- Phase
- NA
Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells) in Children and Adolescents
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Impact of the COVID-19 Pandemic on the Organization of Healthcare in France
- Status
- UNKNOWN
- Phase
- N/A
Safety and Immunogenicity of Adjuvanted SARS-CoV-2 (SCB-2019) Vaccine in Adults With Chronic Immune-Mediated Diseases
- Status
- TERMINATED
- Phase
- PHASE3
Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR).
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Targeting de Novo Pyrimidine Biosynthesis by Leflunomide for the Treatment of COVID-19 Virus Disease
- Status
- COMPLETED
- Phase
- PHASE3
Preventive Dendritic Cell Vaccine, AV-COVID-19, in Subjects Not Actively Infected With COVID-19
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE2
Utilizing the Crosstalk Among Aerosolized Phenformin , Methylene Blue, Photodynamic Therapy , Zinc and Potassium for Treating Severe COVID-19 Infection and Its Inflammatory Complication
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2